stood at 696 crore, up 28% YoY, mainly on account of volume growth in antioxidants and other products, higher raw material costs which were passed through and rupee depreciation. GPM in the quarter came in at 46%, down ~640 bps YoY. EBITDA for the quarter stood at 170.5 crore, up 7% YoY translating...